Sujal Shah

Insider Reports History

Entity
Individual
Location
C/O Cymabay Therapeutics, Inc., 7575 Gateway Blvd., Suite 110, Newark, CA
Signature
/s/ Dan Conn, Attorney- in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sujal Shah:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Common Stock 0 $0 $2.94 Mar 22, 2024 Direct
Tvardi Therapeutics, Inc. Director Stock Option (right to buy) 8.05K Apr 15, 2025 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Stock Appreciation Right 0 Dec 11, 2023 Direct
CymaBay Therapeutics, Inc. Chief Executive Officer, Director Employee Stock Option (right to buy) 0 Mar 22, 2024 Direct

Insider Reports Filed by Sujal Shah

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TVRD Tvardi Therapeutics, Inc. Apr 15, 2025 2 $0 4 Apr 17, 2025 Director
TVRD Tvardi Therapeutics, Inc. Apr 15, 2025 0 $0 3 Apr 17, 2025 Director
CBAY CymaBay Therapeutics, Inc. Mar 22, 2024 15 $0 4 Mar 22, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Mar 13, 2024 18 $656K 4 Mar 15, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 24, 2024 2 $0 4 Jan 26, 2024 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Dec 11, 2023 7 -$973K 4 Dec 11, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Nov 13, 2023 7 -$706K 4 Nov 14, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Oct 9, 2023 5 -$597K 4 Oct 10, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2023 1 $0 4 Jan 27, 2023 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jun 6, 2022 1 $100K 4 Jun 7, 2022 Chief Executive Officer, Director
CBAY CymaBay Therapeutics, Inc. Jan 25, 2022 1 $0 4 Jan 27, 2022 Chief Executive Officer, Director